Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capfi Delen Asset Management is a Belgian investment management firm that serves as the asset management arm of Delen Private Bank. The company is responsible for the creation, administration, and management of a diverse range of investment funds, including equity, fixed-income, and balanced portfolios. While the firm manages thematic funds that may invest in the healthcare and life sciences sectors, it is not a biotechnology or pharmaceutical company and does not conduct clinical research. It operates as a subsidiary of Delen Private Bank, which is part of the Euronext-listed holding company Ackermans & van Haaren. The firm's primary focus is on providing long-term investment solutions for private and institutional clients within the Benelux region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Capfi Delen Asset Management.